Pdndptanlvestlgator/PrDogirreacmtor(LaFsirts,Mt, iddle)M: odlin, Robed L., M.D. DESCRIPTION: State the application's broad, tong-term objectives and spec_c aims, making reference to the health relatedness of _ project Dascd_ on_ the research destg_ and methods for achisvingll'mse goais. Avoid sBnn_das of past __ _ _ u_ of _ _ _. This abstract _s meant to serve as a succinct and accurate description of the proposed work v,t_en separated from the application. If the application is funded, this desc_, as is, will become public _rfocmatton. Therefore, do not includo proprietary/confidential information. IX) NOT EXCEEO THE 8PACE PROVIDED. The long-term objective of this proposal is to gain insight into mechanisms of innate immunity to l_ectious agents in humans, with particular emphasis on the role of TolIJike receptors (TLRs) in cutaneous host defense. Significant findings during the current budget period include the following concepts: 1) activation of TLR2 on human dendritic cells triggers DC maturation and induction of IL-12, but not lL*10; 2) induction of direct antimicrobial activity through mammalian TLRs; 3) involvement of receptor interacting protein 2 in innate and adaptive immune responses; 4) IRF3 mediates a TLR3/TLR4- specific arrtMral gene program; 5) TLR2 Ugands as adjuvants for human Thl responses; 6) activation and regulation of TLRs 2 and 1 in human leprosy correlates with clinical outcome; 7) LIR-7 activation antagonizes TLR activatioo of rnonocyte cytokine release. We propose experiments to investigate the role of TLRs in skin and the innate response to microbial infection. First, we hypothesize that different TLRs have distinct roles in host immunity. We will determine the role of specific TLRs in the cutaneous immune response by comparing the distribution of TLRs in skin lesions, analyzing the role of distinct TLRs in Langerhans cell responses to microbial ligands and determining the mechanism by which TLR activation leads to killing of intracellutar bacteria by studying activation of the vitamin D receptor as a model. Second we hypothesize that distinct TLRs or TLR signaling pathways lead to immunostimulatory events. We propose to determine the role of TLRs in phagocytosis and the signaling pathways that lead to phagocytosis. Third, we hypothesize that the expression of TLR on T cells allows these calls of the adaptive immune system to participate in the innate response. We propose to study the ability of TLRs to trigger monocytes to differentiate into DC, and the effect of DC maturation on antigen presentation to T cells. The role of LIRs in countering the TLR induced differentiation of DC will also be investigated. We believe that the insights obtained form the study of TLRs in skin and their response to microbial lipoproteins will provide new knowledge about the innate immune response and suggest new avenues of immunologic intervention in human disease. PERFORMANCESrTE(S)(organLratbnc, ity,state) David Geffen School of Medicine at UCLA, Los Angeles, California _=Y PERSONNEL See instructions. Use con_ page.s as needed to provide the required information in the fonnat shown below, Start with Principal Investigator. List all olt_r key personnel ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37AI047868-06
Application #
6832368
Study Section
Special Emphasis Panel (NSS)
Program Officer
Minnicozzi, Michael
Project Start
2000-09-01
Project End
2010-02-28
Budget Start
2005-06-01
Budget End
2006-02-28
Support Year
6
Fiscal Year
2005
Total Cost
$295,269
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Schenk, Mirjam; Mahapatra, Sebabrata; Le, Phuonganh et al. (2016) Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae. Infect Immun 84:2429-38
Teles, Rosane M B; Kelly-Scumpia, Kindra M; Sarno, Euzenir N et al. (2015) IL-27 Suppresses Antimicrobial Activity in Human Leprosy. J Invest Dermatol 135:2410-2417
Ma, Feng; Liu, Su-Yang; Razani, Bahram et al. (2014) Retinoid X receptor ? attenuates host antiviral response by suppressing type I interferon. Nat Commun 5:5494
Schenk, Mirjam; Fabri, Mario; Krutzik, Stephan R et al. (2014) Interleukin-1? triggers the differentiation of macrophages with enhanced capacity to present mycobacterial antigen to T cells. Immunology 141:174-80
Teles, Rosane M B; Graeber, Thomas G; Krutzik, Stephan R et al. (2013) Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339:1448-53
Klug-Micu, Georgiana M; Stenger, Steffen; Sommer, Andrea et al. (2013) CD40 ligand and interferon-? induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes. Immunology 139:121-8
Schenk, Mirjam; Krutzik, Stephan R; Sieling, Peter A et al. (2012) NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med 18:555-63
Liu, Philip T; Wheelwright, Matthew; Teles, Rosane et al. (2012) MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med 18:267-73
Parvatiyar, Kislay; Zhang, Zhiqiang; Teles, Rosane M et al. (2012) The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 13:1155-61
Ouyang, Songying; Song, Xianqiang; Wang, Yaya et al. (2012) Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity 36:1073-86

Showing the most recent 10 out of 43 publications